Shiota Seiji, Singh Siddharth, Anshasi Ashraf, El-Serag Hashem B
Section of Gastroenterology and Hepatology, Department of Medicine, Michael E. DeBakey VA Medical Center, and Baylor College of Medicine, Houston, Texas.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Clin Gastroenterol Hepatol. 2015 Nov;13(11):1907-18. doi: 10.1016/j.cgh.2015.07.050. Epub 2015 Aug 7.
BACKGROUND & AIMS: The prevalence and risk factors of Barrett's esophagus (BE) in Asian countries are unclear. Studies report a wide range of BE prevalence in Asian countries. We conducted a systematic review and meta-analysis to examine the prevalence of BE and its temporal changes and risk factors in Asian countries.
Two investigators performed independent literature searches by using PubMed and EMBASE databases, and subsequent data abstraction for studies had to meet several set inclusion and exclusion criteria. Pooled BE prevalence was calculated by using a random-effect model. Estimates of relative risk for possible risk or protective factors were also calculated.
A total of 51 studies (N = 453,147), mainly from Eastern Asia, were included. The pooled prevalence of endoscopic BE was 7.8% (95% confidence interval, 5.0-12.1; 23 studies) and of histologically confirmed BE was 1.3% (95% confidence interval, 0.7-2.2; 28 studies). Most of histologic BE (82.1%) was short-segment BE (<3 cm). There was a trend toward an increase in prevalence of BE over time from 1991 to 2014, especially in Eastern Asian countries. Within BE cohorts, pooled prevalence of low-grade dysplasia, high-grade dysplasia, and esophageal adenocarcinoma was 6.9%, 3.0%, and 2.0%, respectively. Reflux symptoms, male sex, hiatus hernia, and smoking were associated with a significantly increased risk of histologic BE in patients with BE compared with patients without BE. However, half of the patients with histologic BE did not have reflux symptoms.
BE is not uncommon in Asian countries and seems to share similar risk factors and potential for neoplastic progression to those seen in Western countries.
亚洲国家巴雷特食管(BE)的患病率及危险因素尚不清楚。研究报道亚洲国家BE的患病率差异很大。我们进行了一项系统评价和荟萃分析,以研究亚洲国家BE的患病率、其随时间的变化以及危险因素。
两名研究者通过使用PubMed和EMBASE数据库进行独立的文献检索,随后对研究进行数据提取,这些研究必须符合若干既定的纳入和排除标准。采用随机效应模型计算BE的合并患病率。还计算了可能的风险或保护因素的相对风险估计值。
共纳入51项研究(N = 453,147),主要来自东亚。内镜诊断的BE合并患病率为7.8%(95%置信区间,5.0 - 12.1;23项研究),组织学确诊的BE合并患病率为1.3%(95%置信区间,0.7 - 2.2;28项研究)。大多数组织学确诊的BE(82.1%)为短段BE(<3 cm)。从1991年到2014年,BE的患病率有随时间增加的趋势,尤其是在东亚国家。在BE队列中,低级别异型增生、高级别异型增生和食管腺癌的合并患病率分别为6.9%、3.0%和2.0%。与无BE的患者相比,有反流症状、男性、食管裂孔疝和吸烟与BE患者发生组织学确诊BE的风险显著增加相关。然而,一半组织学确诊的BE患者没有反流症状。
BE在亚洲国家并不罕见,其危险因素和肿瘤进展潜力似乎与西方国家相似。